Year All202620252024202320222021202020192018201720162015201420132012 March 18, 2026 Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting March 4, 2026 Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference March 3, 2026 Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication March 2, 2026 Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance February 18, 2026 Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026 February 17, 2026 Harrow Announces Cash-Pay Direct-to-Prescriber PharmaPack™ Kits February 2, 2026 Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth